Loading stock data…
$155.08-0.53 (-0.34%)
Revvity, Inc.
Revvity, Inc. in the Healthcare sector is trading at $155.08 with a market capitalization of $16.4B. Wall Street consensus targets $144.53 (15 analysts), implying a -6.8% move over the next 12 months. The stock is currently near its 52-week high of $166.25, remaining 43.3% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $729.69M↑ | $711.12M↓ | $772.06M↑ | $698.95M↓ | $720.28M |
| Gross Profit | $416.87M↑ | $387.65M↓ | $421.66M↑ | $374.60M↓ | $392.56M |
| Operating Income | $87.85M↑ | $75.89M↓ | $111.75M↑ | $81.90M↓ | $89.06M |
| Net Income | $51.82M↑ | $40.72M↓ | $98.36M↑ | $46.65M↓ | $53.95M |
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents...
Academic risk and quality models computed from RVTY's own filings and price history, not from analyst opinion.
Mixed: 6 of 9 fundamental-health tests pass, so profitability and balance-sheet trends disagree.
Altman Z above the 2.99 safe threshold, so the model puts bankruptcy risk in its lowest band.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
GARCH(1,1) 30-day annualised forecast, above the current 34.6% reading.
Fama-French 5-factor market beta. The five factors explain 27% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-10-13.